Wertheim Fellow, “Tony” Kuang-Ting Kuo, is in the final year of his Ph.D. program in the lab of Scientific Director Patrick Griffin, Ph.D. He recently co-mentored high school student intern Shivangi Saxena. In 2022, Dr. Herbert Wertheim made a transformational $100 million gift to The Herbert Wertheim UF Scripps Institute…
Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.
Patrick Griffin, Ph.D., has dedicated his career to understanding the molecules of life in pursuit of treatments for cancer, diabetes, osteoporosis, obesity and more. Wertheim UF Scripps Scientific Director and Professor Patrick Griffin, Ph.D., helped develop a technique called HDX-MS that solves the challenge of…
As people age and stress their joints, their chondrocytes begin to fail. The UF Scripps team found that activating a specific protein in these cells called RORβ restored their health.
